Custom service

Peptides-Imaging Agents Conjugation

Label peptides with fluorophores, chelators or photosensitizers for imaging studies

Turnaround: 4–6 weeksTypical scale: 0.1–50 mg conjugate per batchChemistry options: NIR fluorophore conjugation (IRDye, Cy5/Cy7 families); DOTA and NOTA chelator installation; photosensitizer coupling for photodynamic studies

The service is built around NIR fluorophore conjugation (IRDye, Cy5/Cy7 families). Depending on the molecule we may move to DOTA and NOTA chelator installation or photosensitizer coupling for photodynamic studies to improve stability, loading or yield, and every batch is released with labeled peptide with dye-to-peptide ratio certificate.

Because Peptides-Imaging Agents Conjugation projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.

In-vivo fluorescence imaging probes

PET/SPECT precursor development

Clinical-grade radiopharmaceutical release

Conjugates whose payload cannot tolerate aqueous coupling conditions

Every conjugation batch is documented from vial to vial: carrier lot, payload lot, reagent lots, reaction conditions and purification chromatograms. The release package contains the loading ratio measured by an orthogonal method (UV, ICP-MS or amino-acid analysis), identity by mass spectrometry where the conjugate permits it, and residual-free-payload data.

Service Highlights

  • NIR fluorophore conjugation (IRDye, Cy5/Cy7 families) as the default route, with DOTA and NOTA chelator installation held as a proven fallback
  • Photosensitizer coupling for photodynamic studies worked into the design where the application requires it
  • Carrier and payload compatibility screened in a small feasibility batch before full material is committed
  • Analytical confirmation of every intermediate before the final release
  • Unreacted payload driven below the detection limit of the release assay before purification is closed
  • Labeled peptide with dye-to-peptide ratio certificate delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Scope & design

    We review the payload, the carrier and the intended assay or study, and propose between NIR fluorophore conjugation (IRDye, Cy5/Cy7 families) and DOTA and NOTA chelator installation as candidate routes.

  2. Feasibility screen

    A milligram-scale screen compares loading, residual payload and activity across the candidate conditions.

  3. Production conjugation

    The selected condition is executed at project scale with in-process sampling at fixed time points.

  4. Purification

    Size-exclusion, dialysis or magnetic separation removes free payload and by-products.

  5. Characterization & release

    Identity, loading ratio and functional activity are measured against the agreed specification.

  6. Documentation & hand-off

    Labeled peptide with dye-to-peptide ratio certificate is packaged with the full batch record, released for shipment after QC sign-off.

Specifications & timeline

Turnaround
4–6 weeks
Typical scale
0.1–50 mg conjugate per batch
Chemistry options
NIR fluorophore conjugation (IRDye, Cy5/Cy7 families); DOTA and NOTA chelator installation; photosensitizer coupling for photodynamic studies
Deliverable
Labeled peptide with dye-to-peptide ratio certificate
QC package
HPLC/SEC trace, MALDI-TOF or ESI-MS, UV/Vis or ICP-MS loading ratio
Shipping
Blue ice or dry ice as the payload requires, with a cold-chain manifest

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.